1 |
Yoshida, H., Murachi, T. and Tsukahara, I. 1985. Distribution of calpain I, calpain II, and calpastatin in bovine lens. Invest Ophthalmol. Vis. Sci. 26, 953-956.
|
2 |
Roulston, A., Reinhard, C., Amiri, P. and Williams, L. T. 1998. Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha. J. Biol. Chem. 273, 10232-10239.
DOI
|
3 |
Santella, L., Kyozuka, K., De Riso, L. and Carafoli, E. 1998. Calcium, protease action, and the regulation of the cell cycle. Cell Calcium. 23, 123-130.
DOI
|
4 |
Wasko, B. M., Dudakovic, A. and Hohl, R. J. 2011. Bisphosphonates induce autophagy by depleting geranylgeranyl diphosphate. J. Pharmacol. Exp. Ther. 337, 540-546.
DOI
|
5 |
Wojtkowiak, J. W., Sane, K. M., Kleinman, M., Sloane, B. F., Reiners, J. J. Jr. and Mattingly, R. R. 2011. Aborted autophagy and nonapoptotic death induced by farnesyl transferase inhibitor and lovastatin. J. Pharmacol. Exp. Ther. 337, 65-74.
DOI
|
6 |
Yamada, M., Banno, Y., Takuwa, Y., Koda, M., Hara, A. and Nozawa, Y. 2004. Overexpression of phospholipase D prevents actinomycin D-induced apoptosis through potentiation of phosphoinositide 3-kinase signalling pathways in Chinese-hamster ovary cells. Biochem. J. 378, 649-656.
DOI
|
7 |
Yoshimura, N., Tsukahara, I. and Murachi, T. 1984. Calpain and calpastatin in porcine retina. Identification and action on microtubule-associated proteins. Biochem. J. 223, 47-51.
DOI
|
8 |
Lee, S. J., Ha, M. J., Lee, J., Nguyen, P., Choi, Y. H., Pirnia, F., Kang, W. K., Wang, X. F., Kim, S. J. and Trepel, J. B. 1998. Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells. J. Biol. Chem. 273, 10618-10623.
DOI
|
9 |
Lim, S. and Kaldis, P. 2013. Cdks, cyclins and CKIs: roles beyond cell cycle regulation. Development. 140, 3079-3093.
DOI
ScienceOn
|
10 |
Mani, A. and Gelmann, E. P. 2005. The ubiquitin-proteasome pathway and its role in cancer. J. Clin. Oncol. 23, 4776-4789.
DOI
|
11 |
Pomerantz, Y. and Dekel, N. 2013. Molecular participants in regulation of the meiotic cell cycle in mammalian oocytes. Reprod. Fertil. Dev. 25, 484-494.
|
12 |
McKenney, J. M. 1998. Lovastatin: a new cholesterol-lowering agent. Clin. Pharm. 7, 21-36.
|
13 |
Meinel, F. G., Mandl-Weber, S., Baumann, P., Leban, J. and Schmidmaier, R. 2010. The novel, proteasome-independent NF-kappaB inhibitor V1810 induces apoptosis and cell cycle arrest in multiple myeloma and overcomes NF-kappaB-mediated drug resistance. Mol. Cancer. Ther. 9, 300-310.
|
14 |
Muşat, M., Vax, V. V., Borboli, N., Gueorguiev, M., Bonner, S., Korbonits, M. and Grossman, A. B. 2004. Cell cycle dysregulation in pituitary oncogenesis. Front. Horm. Res. 32, 34-62.
DOI
|
15 |
Rao, S., Lowe, M., Herliczek, T. W. and Keyomarsi, K. 1998. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53. Oncogene 17, 2393-2402.
DOI
|
16 |
Roos-Mattjus, P. and Sistonen, L. 2004. The ubiquitin-proteasome pathway. Ann. Med. 36, 285-295.
DOI
|
17 |
Friedrich, P. 2004. The intriguing Ca2+ requirement of calpain activation. Biochem. Biophys. Res. Commun. 323, 1131-1133.
DOI
|
18 |
Diaz-Padilla, I., Siu, L. L. and Duran, I. 2009. Cyclin-dependent kinase inhibitors as potential targeted anticancer agents. Invest. New Drugs. 27, 586-594.
DOI
|
19 |
Errico, A., Deshmukh, K., Tanaka, Y., Pozniakovsky, A. and Hunt, T. 2010. Identification of substrates for cyclin dependent kinases. Adv. Enzyme Regul. 50, 375-399.
DOI
|
20 |
Farmer, J. A. and Torre-Amione, G. 2000. Comparative tolerability of the HMG-CoA reductase inhibitors. Drug. Saf. 23, 197-213.
DOI
|
21 |
Graf, F., Mosch, B., Koehler, L., Bergmann, R., Wuest, F. and Pietzsch, J. 2010. Cyclin-dependent kinase 4/6 (cdk4/6) inhibitors: perspectives in cancer therapy and imaging. Mini. Rev. Med. Chem. 10, 527-539.
DOI
|
22 |
Kim, J. S., Pirnia, F., Choi, Y. H., Nguyen, P. M., Knepper, B., Tsokos, M., Schulte, T. W., Birrer, M. J., Blagosklonny, M. V., Schaefer, O., Mushinski, J. F. and Trepel, J. B. 2000. Lovastatin induces apoptosis in a primitive neuroectodermal tumor cell line in association with RB down-regulation and loss of the G1 checkpoint. Oncogene 19, 6082-6090.
DOI
|
23 |
Konstantinova, I. M., Tsimokha, A. S. and Mittenberg, A. G. 2008. Role of proteasomes in cellular regulation. Int. Rev. Cell Mol. Biol. 267, 59-124.
DOI
|
24 |
Bertipaglia, I. and Carafoli, E. 2007. Calpains and human disease. Subcell. Biochem. 45, 29-53.
DOI
|
25 |
Bogner, C., Schneller, F., Hipp, S., Ringshausen, I., Peschel, C. and Decker, T. 2003. Cycling B-CLL cells are highly susceptible to inhibition of the proteasome: involvement of p27, early D-type cyclins, Bax, and caspase-dependent and -independent pathways. Exp. Hematol. 31, 218-225.
DOI
|
26 |
Huo, L. J., Fan, H. Y., Zhong, Z. S., Chen, D. Y., Schatten, H. and Sun, Q. Y. 2004. Ubiquitin-proteasome pathway modulates mouse oocyte meiotic maturation and fertilization via regulation of MAPK cascade and cyclin B1 degradation. Mech. Dev. 121, 1275-1287.
DOI
|
27 |
Chen, F. Z. and Zhao, X. K. 2013. Ubiquitin-proteasome pathway and prostate cancer. Onkologie 36, 592-596.
DOI
|
28 |
Choi, Y. H., Lee, S. J., Nguyen, P., Jang, J. S., Lee, J., Wu, M. L., Takano, E., Maki, M., Henkart, P. A. and Trepel, J. B. 1997. Regulation of cyclin D1 by calpain protease. J. Biol. Chem. 272, 28479-28484.
DOI
|